Ole Andreas Halvorsen's Net Worth
$0
Who is Ole Andreas Halvorsen?
Ole Andreas Halvorsen does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adaptive Biotechnologies Corp, Roivant Sciences Ltd., Wayfair Inc., Urovant Sciences Ltd., Myovant Sciences Ltd., FIRST DATA CORP, Arbutus Biopharma Corp, APi Group Corp, Axovant Sciences Ltd., BridgeBio Pharma, Inc., Amylyx Pharmaceuticals, Inc., Zentalis Pharmaceuticals, LLC, RayzeBio, Inc., Editas Medicine, Inc., Inhibrx, Inc., PROCEPT BioRobotics Corp, 4D Molecular Therapeutics, Inc., Rallybio Corp, Ginkgo Bioworks Holdings, Inc., FIGS, Inc., Frazier Lifesciences Acquisition Corp, STANDARD BIOTOOLS INC., and Inhibrx Biosciences, Inc..
SEC CIK
Ole Andreas Halvorsen's CIK is 0001133006
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Amylyx Pharmaceuticals, Inc. (AMLX) Snapshot price: $2.37
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -10.26% | -1.40M |
$29.80 | -$41,719,639.31 | 12.24M |
Sep 8 - Sep 9
| |||
Form 4
|
∞
| 7.17M |
$19.00 | $43,700,000.00 | 7.17M |
Jan 11 - Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adaptive Biotechnologies Corp (ADPT) Snapshot price: $4.21
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.23% | -1.00M |
$55.65 | -$55,650,000.00 | 29.99M |
Dec 14
| |||
Form 4
| -7.46% | -2.50M |
$49.52 | -$123,787,500.00 | 30.99M |
Nov 11
| |||
Form 4
| -7.46% | -2.50M |
$49.52 | -$123,787,500.00 | 30.99M |
Nov 11
| |||
Form 4
| -12.79% | -4.91M |
$24.98 | -$122,706,039.29 | 33.49M |
Jan 28
| |||
Form 4
| -12.79% | -4.91M |
$24.98 | -$122,706,039.29 | 33.49M |
Jan 28
| |||
Form 4
| +2,595.20% | 36.98M |
$20.00 |
—
| 38.41M |
Jul 1
| |||
Form 4
| +2,595.20% | 36.98M |
$20.00 |
—
| 38.41M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zentalis Pharmaceuticals, LLC (ZNTL) Snapshot price: $2.96
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -11.25% | -500.00K |
$50.50 | -$25,250,000.00 | 3.94M |
Dec 1
| |||
Form 4
| +19.50% | 725K |
$18.00 | $13,050,000.00 | 4.44M |
Apr 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RayzeBio, Inc. (RYZB) No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.64M |
—
|
—
|
0
|
Feb 26
| |||
Form 4
| -100.00% | -6.64M |
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
∞
| 6.64M |
$18.00 |
—
| 6.64M |
Sep 19
| |||
Form 4
|
∞
| 6.64M |
$18.00 |
—
| 6.64M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $3.57
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 5.46M |
—
|
—
| 5.46M |
Feb 8 - Feb 8
| |||
Form 4
|
∞
| 5.46M |
—
|
—
| 5.46M |
Feb 8 - Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||